Literature DB >> 2118867

Comparison of vancomycin-inducible proteins from four strains of Enterococci.

S al-Obeid1, L Gutmann, D M Shlaes, R Williamson, E Collatz.   

Abstract

Vancomycin-inducible proteins of 39.5 and 39 kDa from respectively, low-level and high-level resistant Enterococci were compared. Electrophoretic, immunoblot and peptide analysis revealed three types of protein, one in a low-level resistant strain of E. faecium, one in 2 high-level-resistant strains of E. faecium, and one in a high-level resistant strain of E. faecalis. The inducible proteins of E. faecium and E. faecalis, of 39.5 and 39 kDa respectively, which may function in a similar fashion (Al-Obeid et al. (1990) Antimicrob. Agents Chemother. 34, 252-256), are not related immunologically.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2118867     DOI： 10.1016/0378-1097(90)90110-c

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN： 0378-1097            Impact factor:   2.742


  18 in total

1.  Detection of glycopeptide resistance genotypes and identification to the species level of clinically relevant enterococci by PCR.

Authors:  S Dutka-Malen; S Evers; P Courvalin
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

Review 2.  Current perspectives on glycopeptide resistance.

Authors:  N Woodford; A P Johnson; D Morrison; D C Speller
Journal:  Clin Microbiol Rev       Date:  1995-10       Impact factor: 26.132

3.  Semisynthetic glycopeptide antibiotics derived from LY264826 active against vancomycin-resistant enterococci.

Authors:  T I Nicas; D L Mullen; J E Flokowitsch; D A Preston; N J Snyder; M J Zweifel; S C Wilkie; M J Rodriguez; R C Thompson; R D Cooper
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 4.  Genetics and mechanisms of glycopeptide resistance in enterococci.

Authors:  M Arthur; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

5.  Emergence of clinical isolates of Escherichia coli producing TEM-1 derivatives or an OXA-1 beta-lactamase conferring resistance to beta-lactamase inhibitors.

Authors:  X Y Zhou; F Bordon; D Sirot; M D Kitzis; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1994-05       Impact factor: 5.191

6.  Emergence of high-level resistance to glycopeptides in Enterococcus gallinarum and Enterococcus casseliflavus.

Authors:  S Dutka-Malen; B Blaimont; G Wauters; P Courvalin
Journal:  Antimicrob Agents Chemother       Date:  1994-07       Impact factor: 5.191

7.  Constitutively vancomycin-resistant Enterococcus faecium resistant to synergistic beta-lactam combinations.

Authors:  M Green; B Binczewski; A W Pasculle; M Edmund; K Barbadora; S Kusne; D M Shlaes
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

8.  Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.

Authors:  F Caron; M D Kitzis; L Gutmann; A C Cremieux; B Maziere; J M Vallois; A Saleh-Mghir; J F Lemeland; C Carbon
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

9.  Bactericidal activities of antibiotics against vancomycin-resistant Enterococcus faecium blood isolates and synergistic activities of combinations.

Authors:  M K Hayden; G I Koenig; G M Trenholme
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

10.  Inducible carboxypeptidase activity in vancomycin-resistant enterococci.

Authors:  L Gutmann; D Billot-Klein; S al-Obeid; I Klare; S Francoual; E Collatz; J van Heijenoort
Journal:  Antimicrob Agents Chemother       Date:  1992-01       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.